Nothing Special   »   [go: up one dir, main page]

SMT201400082B - Derivato di imidazotiazolo avente struttura ad anello prolinico - Google Patents

Derivato di imidazotiazolo avente struttura ad anello prolinico

Info

Publication number
SMT201400082B
SMT201400082B SM201400082T SM201400082T SMT201400082B SM T201400082 B SMT201400082 B SM T201400082B SM 201400082 T SM201400082 T SM 201400082T SM 201400082 T SM201400082 T SM 201400082T SM T201400082 B SMT201400082 B SM T201400082B
Authority
SM
San Marino
Prior art keywords
ring structure
proline ring
imidazothiazole derivative
imidazothiazole
derivative
Prior art date
Application number
SM201400082T
Other languages
English (en)
Inventor
Kouichi Uoto
Yuuichi Sugimoto
Hiroyuki Naito
Masaki Miyazaki
Keisuke Yoshida
Masashi Aonuma
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SMT201400082B publication Critical patent/SMT201400082B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/499Spiro-condensed pyrazines or piperazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
SM201400082T 2009-01-16 2014-06-25 Derivato di imidazotiazolo avente struttura ad anello prolinico SMT201400082B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009007536 2009-01-16
PCT/JP2010/050372 WO2010082612A1 (ja) 2009-01-16 2010-01-15 プロリン環構造を有するイミダゾチアゾール誘導体

Publications (1)

Publication Number Publication Date
SMT201400082B true SMT201400082B (it) 2014-09-08

Family

ID=42339866

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400082T SMT201400082B (it) 2009-01-16 2014-06-25 Derivato di imidazotiazolo avente struttura ad anello prolinico

Country Status (24)

Country Link
US (2) US8404691B2 (it)
EP (1) EP2380892B1 (it)
JP (1) JP5520236B2 (it)
KR (1) KR20110119641A (it)
CN (1) CN102356085A (it)
AU (1) AU2010205201A1 (it)
BR (1) BRPI1007334A2 (it)
CA (1) CA2750009A1 (it)
CO (1) CO6420347A2 (it)
CY (1) CY1115234T1 (it)
DK (1) DK2380892T3 (it)
ES (1) ES2463820T3 (it)
HR (1) HRP20140409T1 (it)
IL (1) IL214117A0 (it)
MX (1) MX2011007598A (it)
PL (1) PL2380892T3 (it)
PT (1) PT2380892E (it)
RU (1) RU2011134283A (it)
SG (1) SG173028A1 (it)
SI (1) SI2380892T1 (it)
SM (1) SMT201400082B (it)
TW (1) TW201030011A (it)
WO (1) WO2010082612A1 (it)
ZA (1) ZA201105132B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2009151069A1 (ja) * 2008-06-12 2011-11-17 第一三共株式会社 4,7−ジアザスピロ[2.5]オクタン環構造を有するイミダゾチアゾール誘導体
MX342958B (es) 2011-03-10 2016-10-18 Daiichi Sankyo Co Ltd Derivados de diespiropirrolidina.
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
US20170283885A1 (en) * 2014-10-09 2017-10-05 Daiichi Sankyo Company, Limited Algorithms for gene signature-based predictor of sensitivity to mdm2 inhibitors
EP3458101B1 (en) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
EP3360865A1 (en) 2017-02-13 2018-08-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of cyclopropyldiketopiperazines, and of a key intermediate of ds-5272
CN111943894A (zh) * 2019-05-17 2020-11-17 南京爱德程医药科技有限公司 一种4,7-二氮杂螺[2.5]辛烷类化合物的合成方法
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000072743A (ja) 1998-08-31 2000-03-07 Japan Science & Technology Corp アルケンのアジリジン化法
US6740495B1 (en) 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US6979551B2 (en) 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
DE60227108D1 (de) 2001-12-18 2008-07-24 Hoffmann La Roche Cis-imidazoline als mdm2-hemmer
RU2305095C2 (ru) 2001-12-18 2007-08-27 Ф.Хоффманн-Ля Рош Аг Цис-2,4,5-трифенилимидазолины и фармацевтическая композиция на их основе
US7132421B2 (en) 2003-06-17 2006-11-07 Hoffmann-La Roche Inc. CIS-imidazoles
MXPA05013279A (es) 2003-06-17 2006-03-09 Hoffmann La Roche Cis-2,4,5-triaril-imidazolinas.
US7425638B2 (en) 2003-06-17 2008-09-16 Hoffmann-La Roche Inc. Cis-imidazolines
AU2004253245B2 (en) 2003-06-17 2010-02-11 F. Hoffmann-La Roche Ag CIS-imidazolines as MDM2 inhibitors
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
JP2005075754A (ja) 2003-08-29 2005-03-24 Mitsui Chemicals Inc トランス−1,2−ビス(3,5−ジメチルフェニル)−1,2−エタンジアミンの光学分割方法
ES2314660T3 (es) 2004-05-18 2009-03-16 F. Hoffmann-La Roche Ag Nuevas cis-imidazolinas.
US7893278B2 (en) 2004-06-17 2011-02-22 Hoffman-La Roche Inc. CIS-imidazolines
JP4870778B2 (ja) 2005-12-01 2012-02-08 エフ.ホフマン−ラ ロシュ アーゲー 抗ガン剤として使用されるp53およびmdm2タンパク質間の相互作用の阻害剤としての2,4,5−トリフェニルイミダゾリン誘導体
JP5019102B2 (ja) * 2006-12-14 2012-09-05 東芝機械株式会社 ガラス成形用金型の製造方法
JPWO2008072655A1 (ja) * 2006-12-14 2010-04-02 第一三共株式会社 イミダゾチアゾール誘導体
EP2142535A2 (en) * 2007-03-29 2010-01-13 Novartis Ag 3-imidazolyl-indoles for the treatment of proliferative diseases
US7625895B2 (en) 2007-04-12 2009-12-01 Hoffmann-Le Roche Inc. Diphenyl-dihydro-imidazopyridinones
JP2009298713A (ja) * 2008-06-11 2009-12-24 Daiichi Sankyo Co Ltd イミダゾチアゾール誘導体
JPWO2009151069A1 (ja) 2008-06-12 2011-11-17 第一三共株式会社 4,7−ジアザスピロ[2.5]オクタン環構造を有するイミダゾチアゾール誘導体

Also Published As

Publication number Publication date
WO2010082612A1 (ja) 2010-07-22
ZA201105132B (en) 2012-03-28
KR20110119641A (ko) 2011-11-02
CY1115234T1 (el) 2017-01-04
EP2380892B1 (en) 2014-04-02
IL214117A0 (en) 2011-08-31
BRPI1007334A2 (pt) 2016-02-10
PL2380892T3 (pl) 2014-08-29
US20130172362A1 (en) 2013-07-04
TW201030011A (en) 2010-08-16
EP2380892A1 (en) 2011-10-26
ES2463820T3 (es) 2014-05-29
CO6420347A2 (es) 2012-04-16
CA2750009A1 (en) 2010-07-22
PT2380892E (pt) 2014-06-09
CN102356085A (zh) 2012-02-15
JPWO2010082612A1 (ja) 2012-07-05
JP5520236B2 (ja) 2014-06-11
EP2380892A4 (en) 2012-08-29
DK2380892T3 (da) 2014-06-30
RU2011134283A (ru) 2013-02-27
SG173028A1 (en) 2011-08-29
US20110301176A1 (en) 2011-12-08
US8404691B2 (en) 2013-03-26
SI2380892T1 (sl) 2014-05-30
HRP20140409T1 (hr) 2014-06-06
MX2011007598A (es) 2011-08-08
AU2010205201A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
NO2020046I1 (no) Ledipasvir - forlenget SPC
CY2017026I2 (el) Τετρακυκλικη ενωση
SMT201400082B (it) Derivato di imidazotiazolo avente struttura ad anello prolinico
BRPI1006760A2 (pt) montagem
BR112012015612A2 (pt) novo derivado de 3-hidróxi-5-arilisotiazol
BRPI1014603A2 (pt) pistão
BRPI1013868A2 (pt) composto diaciletilenodiamina
FI20105032A0 (fi) Paineilmarengas
BR112012000856A2 (pt) tampa
UA20717S (uk) Двигун-генератор
IT1394243B1 (it) Anello di tenuta
DOP2011000348A (es) Construcciones casb7439
BR112012005363A2 (pt) anel de pistão de partes múltiplas
DOP2011000242A (es) Macrolido anti-inflamatorio
BR112012009784A2 (pt) composto benzazepínico
FR2946241B1 (fr) Zesteur a savon
BRPI1007893A2 (pt) derivado de cianopirimidina
DE112009005090A5 (de) Ringmontagepistole
FI20095580A0 (fi) Kaivo
FI20096353A0 (fi) Mäntämoottori
ES1072578Y (es) Anillo percutor
ES1069922Y (es) Anillo
TH101918B (th) แหวน
TH101919B (th) แหวน
TH107809B (th) แหวนยึดติด